Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Screening in 2012
Cancer Medicine · 2025
DOI: 10.1002/cam4.70624 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2025. Verfasst von H Scott McGinnis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Prostate-Specific Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Objectives
The 2012 United States Preventive Services Task Force (USPSTF) Grade D recommendation against prostate‐specific antigen (PSA) screening has resulted in a shift to higher‐stage prostate cancer (PC) at diagnosis. We evaluate the utilization of radical prostatectomy (RP) versus radiation therapy (RT) in the US for Gleason grade group 5 (GG5) prostate cancer before and after 2012.
Methods
We identified 34,011 men with localized GG5 PC undergoing primary therapy with (1) RP or (2) RT + androgen deprivation therapy (ADT) between 2004 and 2017 from the National Cancer Database. The chi‐square test was used to compare the relative use of RP and RT before versus after 2012. Annual use of RP versus RT from 2004 to 2017 was compared using Cochran‐Armitage test for trend. We modeled the effect of treatment year on the use of RP using multivariable logistic regression.
Results
Across all centers, the use of RP increased from 31% to 41% ( p for trend < 0.001). 2012 was associated with significant inflection for increase in RP use in all centers. There was an increased odds of receiving RP after 2012 (adjusted OR 1.34, 95% CI 1.28–1.40, p < 0.001).
Conclusions
Utilization of RP for GG5 PC has significantly increased in the United States over the past decade. It remains unknown if outcomes may be compromised in this group of high‐risk men, many of whom require post‐prostatectomy RT and/or ADT. Prospective comparison of RP versus RT + ADT for GG5 PC are needed to determine optimal treatment for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Epidemiology and Biostatistics, The University of Arizona, Tucson, Arizona, USA.
ORCID-Profile: H Scott McGinnis
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
McGinnis, H. S., Corriher, T., Janopaul-Naylor, J., Goyal, S., Liu, Y., Wang, Z., & Patel, S. A. (2025). Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Screening in 2012. Cancer Medicine. https://doi.org/10.1002/cam4.70624
Vancouver
McGinnis HS, Corriher T, Janopaul-Naylor J, Goyal S, Liu Y, Wang Z, et al. Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Screening in 2012. Cancer Medicine. 2025. doi:10.1002/cam4.70624
BibTeX
@article{McGinnis2025,
author = {McGinnis, H Scott and Corriher, Taylor and Janopaul-Naylor, James and Goyal, Subir and Liu, Yuan and Wang, Zelin and Patel, Sagar A},
title = {Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Screening in 2012},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70624}
}
EUVIMED